Organization
Idera Pharmaceuticals, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Idera Pharmaceuticals, Inc.
... EXTON, Pa. and CAMBRIDGE, Mass., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage biopharmaceutical company focused on the discovery, development and ...
... the body's immune system to fight cancer. The Committee has added Idera Pharmaceuticals (Nasdaq: IDRA), Nektar Therapeutics (Nasdaq: NKTR) and Pieris Pharmaceuticals (Nasdaq: PIRS) to ...
... WallStEquities.com has issued free tailored Stock Review on DMPI, GALE, HTBX, and IDRA which is a click away athttp://www.wallstequities.com/registration. This morning's focus is shifted on ...
... CAMBRIDGE, Mass. and EXTON, Pa., Nov. 29, 2017 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics ...
... CAMBRIDGE, Mass. and EXTON, Pa., Nov. 27, 2017 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics ...
... focus in the biotech industry. Regen Biopharma, Inc. (OTC: RGBP), Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), Inovio Pharmaceuticals Inc. (NASDAQ: INO), OncoMed Pharmaceuticals Inc. (NASDAQ: OMED), ...
... CAMBRIDGE, Mass. and EXTON, Pa., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics ...
... second quarter 2019 CAMBRIDGE, Mass., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage biopharmaceutical company focused on the discovery, development and ...
... CAMBRIDGE, Mass. and EXTON, Pa, Oct. 24, 2017 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) ("Idera" or the "Company") today announced that it intends to ...
... If you want a Stock Review on GALE, IDRA, RXDX, or JAGX then come over tohttp://dailystocktracker.com/register/and sign up for your free ...
... that has Clovis CEO Patrick Mahaffey hopeful about an expanded FDA approval. Idera Pharmaceuticals has posted early clinical data suggesting its TLR9 agonist improves outcomes ...
... Idera Pharmaceuticals has posted early clinical data suggesting its TLR9 agonist improves outcomes ...
... CAMBRIDGE, Mass. and EXTON, Pa., Sept. 08, 2017 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics ...
... CAMBRIDGE, Mass. and EXTON, Pa., Sept. 06, 2017 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics ...
... IDERA , a provider of end-to-end database productivity tools, today announced the results ...
... IDERA , a leading provider of database lifecycle management solutions, has released ER/Studio ...
... CAMBRIDGE, Mass. and EXTON, Pa., Aug. 11, 2017 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics ...
... If you want a Stock Review on IDRA, PIRS, PPHM or RTTR then come over tohttp://dailystocktracker.com/register/and sign up for your ...
... CAMBRIDGE, Mass. and EXTON, Pa., June 22, 2017 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics ...
... Pharma AB, Hanmi Pharmaceuticals Co Ltd, HitGen LTD, Horizon Pharma Plc, Idera Pharmaceuticals Inc, Immunocore Ltd, Immunomedics Inc, Immupharma Plc, Incanthera Ltd, Incyte Corp, InteRNA ...
... CAMBRIDGE, Mass. and EXTON, Pa., June 05, 2017 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics ...
Want to see the full history on Idera Pharmaceuticals, Inc.? Upgrade to RelSci Pro now!
Start My Free Trial